Protected carotid-artery stenting versus endarterectomy in high-risk patients.

Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57

Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet (2010) 7.62

Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48

Short term and intermediate term comparison of endarterectomy versus stenting for carotid artery stenosis: systematic review and meta-analysis of randomised controlled clinical trials. BMJ (2010) 2.83

Temporal trends in safety of carotid endarterectomy in asymptomatic patients: systematic review. Neurology (2015) 2.69

Endovascular treatment with angioplasty or stenting versus endarterectomy in patients with carotid artery stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial. Lancet Neurol (2009) 2.20

Operator experience and carotid stenting outcomes in Medicare beneficiaries. JAMA (2011) 2.12

Myocardial infarction after carotid stenting and endarterectomy: results from the carotid revascularization endarterectomy versus stenting trial. Circulation (2011) 1.78

Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience (2008) 1.73

Stroke and death after carotid endarterectomy and carotid artery stenting with and without high risk criteria. J Vasc Surg (2010) 1.73

The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): stenting versus carotid endarterectomy for carotid disease. Stroke (2010) 1.69

Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial). J Am Coll Cardiol (2011) 1.60

Open-cell versus closed-cell stent design differences in blood flow velocities after carotid stenting. J Vasc Surg (2009) 1.58

Does sex matter? Thirty-day stroke and death rates after carotid artery stenting in women versus men: results from the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) lead-in phase. Stroke (2009) 1.54

Carotid artery stenting and patient outcomes: the CABANA surveillance study. Catheter Cardiovasc Interv (2014) 1.45

Carotid endarterectomy versus carotid artery stenting: findings in regard to neuroclinical outcomes and diffusion-weighted imaging. Tex Heart Inst J (2008) 1.40

Impact of chronic renal insufficiency on the early and late clinical outcomes of carotid artery stenting using serum creatinine vs glomerular filtration rate. J Am Coll Surg (2014) 1.38

Carotid stenting done exclusively by vascular surgeons: first 175 cases. Ann Surg (2005) 1.38

Simulation improves resident performance in catheter-based intervention: results of a randomized, controlled study. Ann Surg (2006) 1.35

The Carotid Revascularization Endarterectomy vs. Stenting Trial completes randomization: lessons learned and anticipated results. J Vasc Surg (2009) 1.30

Ethics and methods in surgical trials. J Med Ethics (2009) 1.28

Interventions to increase enrollment in a large multicenter phase 3 trial of carotid stenting vs. endarterectomy. Int J Stroke (2012) 1.02

Symptomatic and asymptomatic carotid artery plaque. Expert Rev Cardiovasc Ther (2011) 1.01

Systematic Review and Meta-Analysis of Carotid Artery Stenting Versus Endarterectomy for Carotid Stenosis: A Chronological and Worldwide Study. Medicine (Baltimore) (2015) 1.00

Carotid stenting vs endarterectomy: new results in perspective. Mayo Clin Proc (2010) 0.98

Killer proteases and little strokes--how the things that do not kill you make you stronger. J Cereb Blood Flow Metab (2006) 0.96

Carotid endarterectomy and carotid artery stenting utilization trends over time. BMC Neurol (2012) 0.95

Cerebral ischemia detected with diffusion-weighted MR imaging after protected carotid artery stenting: comparison of distal balloon and filter device. Korean J Radiol (2007) 0.94

Inflammatory biomarkers in atherosclerosis: pentraxin 3 can become a novel marker of plaque vulnerability. PLoS One (2014) 0.93

Carotid Stenting without Angioplasty and without Protection: The Advantages of a Less Invasive Procedure. Interv Neuroradiol (2008) 0.92

Risk factor management to prevent first stroke. Neurol Clin (2008) 0.92

Differential outcomes of carotid stenting and endarterectomy performed exclusively by vascular surgeons in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). J Vasc Surg (2012) 0.91

Secondary stroke prevention: patent foramen ovale, aortic plaque, and carotid stenosis. Eur Heart J (2012) 0.91

Carotid artery stenting: current and emerging options. Med Devices (Auckl) (2014) 0.90

Ultrasonographic character of carotid plaque and postprocedural brain embolisms in carotid artery stenting and carotid endarterectomy. Ann Vasc Dis (2011) 0.87

Recommendations for management of patients with carotid stenosis. Stroke Res Treat (2012) 0.87

Composition of the stable carotid plaque: insights from a multidetector computed tomography study of plaque volume. Stroke (2007) 0.87

Near/far matching: a study design approach to instrumental variables. Health Serv Outcomes Res Methodol (2012) 0.87

Carotid revascularization: risks and benefits. Vasc Health Risk Manag (2014) 0.87

Increased expression of inhibitor of apoptosis proteins in atherosclerotic plaques of symptomatic patients with carotid stenosis. Exp Mol Pathol (2007) 0.87

Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at standard surgical risk: results from the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). Stroke (2012) 0.87

Medicare's policy on carotid stents limited use to hospitals meeting quality guidelines yet did not hurt disadvantaged. Health Aff (Millwood) (2011) 0.87

Factors Associated with Increased Rates of Post-procedural Stroke or Death following Carotid Artery Stent Placement: A Systematic Review. J Vasc Interv Neurol (2014) 0.87

The effect of postoperative stroke and myocardial infarction on long-term survival after carotid revascularization. J Vasc Surg (2013) 0.86

The interventionalism of medicine: interventional radiology, cardiology, and neuroradiology. Int Arch Med (2009) 0.86

Carotid artery stenting - current status of the procedure. Arch Med Sci (2013) 0.86

In stent restenosis predictors after carotid artery stenting. Stroke Res Treat (2010) 0.86

Carotid-artery stenting in a high-risk patient population--single centre, single operator results. Clin Res Cardiol (2006) 0.85

Intracranial angioplasty and stenting for cerebral atherosclerosis: new treatments for stroke are needed! Neuroradiology (2006) 0.85

Carotid artery stenting: review of technique and update of recent literature. Semin Intervent Radiol (2013) 0.85

Asymptomatic carotid stenosis: What we can learn from the next generation of randomized clinical trials. JRSM Cardiovasc Dis (2014) 0.85

Current strategies for ischemic stroke prevention: role of multimodal combination therapies. J Neurol (2007) 0.84

A cost-effectiveness analysis of carotid artery stenting compared with endarterectomy. J Stroke Cerebrovasc Dis (2010) 0.84

Diagnostic vascular ultrasonography with the help of color Doppler and contrast-enhanced ultrasonography. Ultrasonography (2016) 0.84

Where will the next generation of stroke treatments come from? PLoS Med (2010) 0.84

Ultrasonic tissue characterization of vulnerable carotid plaque: correlation between videodensitometric method and histological examination. Cardiovasc Ultrasound (2006) 0.84

Double embolic protection during carotid artery stenting with persistent hypoglossal artery. BMJ Case Rep (2013) 0.84

The impact of Centers for Medicare and Medicaid Services high-risk criteria on outcome after carotid endarterectomy and carotid artery stenting in the SVS Vascular Registry. J Vasc Surg (2013) 0.83

Outcome evaluation of carotid stenting in high-risk patients with symptomatic carotid near occlusion. Interv Neuroradiol (2010) 0.83

Experience of Staged Angioplasty to Avoid Hyperperfusion Syndrome for Carotid Artery Stenosis. Neurol Med Chir (Tokyo) (2015) 0.83

Grading of carotid artery stenosis with multidetector-row CT angiography: visual estimation or caliper measurements? Eur Radiol (2009) 0.83

Carotid artery stenting in asymptomatic and surgically high-risk patients: single-centre, single-operator results. Int J Angiol (2008) 0.82

Stenting for carotid-artery stenosis. N Engl J Med (2004) 0.82

Comparative effectiveness of carotid arterial stenting versus endarterectomy. J Vasc Surg (2009) 0.82

Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 years. Am Heart J (2009) 0.82

Management of asymptomatic carotid stenosis in patients undergoing general and vascular surgical procedures. J Neurol Neurosurg Psychiatry (2005) 0.82

Secondary prevention of atherothrombotic events after ischemic stroke. Mayo Clin Proc (2009) 0.81

Multimodality management of carotid artery stenosis: reviewing the class-I evidence. J Natl Med Assoc (2007) 0.81

Intravitreal bevacizumab injection and carotid artery stent replacement for neovascular glaucoma in internal carotid artery occlusion. Clin Ophthalmol (2010) 0.81

Carotid artery stenting versus endarterectomy: a systematic review. Tex Heart Inst J (2012) 0.81

Preoperative symptom type influences the 30-day perioperative outcomes of carotid endarterectomy and carotid stenting in the Society for Vascular Surgery Vascular Registry. J Vasc Surg (2014) 0.81

Safety and efficacy assessment of carotid artery stenting in a high-risk population in a single-centre registry. Postepy Kardiol Interwencyjnej (2014) 0.81

The development of carotid stent material. Interv Neurol (2015) 0.81

Plaque vulnerability in internal carotid arteries with positive remodeling. Cerebrovasc Dis Extra (2011) 0.81

Haemodynamic alterations in cerebral blood vessels after carotid artery revascularisation: quantitative analysis using 2D phase-contrast MRI. Eur Radiol (2013) 0.80

Dilation of the Internal Carotid Artery at the Entrance to the Carotid Canal following Carotid Artery Stenting Predicts Postprocedural Hyperperfusion. Interv Neurol (2013) 0.80

Evaluation of Carotid Artery Plaque Using IVUS Virtual Histology. Interv Neuroradiol (2007) 0.80

Carotid stenting versus endarterectomy in patients undergoing reintervention after prior carotid endarterectomy. J Vasc Surg (2013) 0.80

The results of a new distal protection method in intervention for chronic total occlusion of the superficial femoral artery. Cardiol Res Pract (2009) 0.80

Intracranial atherosclerotic disease; current options for surgical or medical treatment. J Korean Neurosurg Soc (2007) 0.80

Prevalence of concomitant atherosclerotic arterial diseases in patients with significant cervical carotid artery stenosis in Taiwan. Int J Cardiovasc Imaging (2006) 0.80

Association of CYP2C19 Polymorphisms with the Clinical Efficacy of Clopidogrel Therapy in Patients Undergoing Carotid Artery Stenting in Asia. Sci Rep (2016) 0.80

Glycoprotein IIb/IIIa antagonists during carotid artery stenting: results from the carotid artery stenting (CAS) registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). Clin Res Cardiol (2007) 0.80

Fragmentation of calcified plaque after carotid artery stenting in heavily calcified circumferential stenosis. Neuroradiology (2009) 0.79

[Position paper on the indication for and implementation of interventional treatment of extracranial carotid stenosis]. Clin Res Cardiol (2006) 0.79

The Angioguard embolic protection device. Expert Rev Med Devices (2008) 0.79

Stroke prevention-surgical and interventional approaches to carotid stenosis. Neurotherapeutics (2011) 0.79

Antiplatelet therapy for carotid artery stenting. Interv Neurol (2013) 0.79

Refinement of Imaging Predictors of Recurrent Events following Transient Ischemic Attack and Minor Stroke. PLoS One (2013) 0.79

Stratifying carotid diseases for endovascular treatments. Interv Neurol (2012) 0.79

Chinese guidelines for endovascular management of ischemic cerebrovascular diseases. Interv Neurol (2013) 0.79

Recovery of cerebrovascular reserves after stenting for symptomatic carotid artery stenosis. Interv Neuroradiol (2010) 0.79

Acute ischemic stroke imaging: a practical approach for diagnosis and triage. Int J Cardiovasc Imaging (2015) 0.78

Carotid artery stenting in clinical practice results from the Carotid Artery Stenting (CAS)-registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Z Kardiol (2005) 0.78

Management of extracranial carotid artery disease. Cardiol Clin (2015) 0.78

Carotid stenting in acute ischemic stroke patients with intraluminal thrombus. Neuroradiology (2010) 0.78

Short- and long-term outcome after carotid artery stenting with neuroprotection: single-center experience within a prospective registry. Clin Res Cardiol (2007) 0.78

Stent-supported angioplasty versus endarterectomy for carotid artery stenosis: evidence from current randomized trials. Z Kardiol (2005) 0.78

The role of endovascular expertise in carotid artery stenting: results from the ALKK-CAS-Registry in 5,535 patients. Clin Res Cardiol (2012) 0.78

Association between carotid plaque composition assessed by multidetector computed tomography and cerebral embolism after carotid stenting. Neuroradiology (2011) 0.78

Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57

A controlled trial of renal denervation for resistant hypertension. N Engl J Med (2014) 14.22

Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med (2003) 13.29

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med (2004) 11.86

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med (2014) 10.54

Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med (2013) 8.91

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation (2011) 6.36

Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med (2014) 5.88

Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med (2007) 5.77

Comparative effectiveness of revascularization strategies. N Engl J Med (2012) 5.49

Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med (2006) 5.39

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med (2007) 5.37

Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation (2011) 5.16

Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation (2011) 4.95

Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med (2008) 4.72

Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. N Engl J Med (2015) 3.69

The endovascular management of visceral artery aneurysms and pseudoaneurysms. J Vasc Surg (2007) 3.56

Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol (2011) 3.37

Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation (2007) 3.34

Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med (2010) 3.27

One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation (2004) 3.23

Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA (2005) 3.06

Nonemergency PCI at hospitals with or without on-site cardiac surgery. N Engl J Med (2013) 2.98

Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease. N Engl J Med (2015) 2.97

A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med (2007) 2.91

Lack of association between migraine headache and patent foramen ovale: results of a case-control study. Circulation (2010) 2.88

Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study. J Am Coll Cardiol (2005) 2.87

Zotarolimus-eluting peripheral stents for the treatment of erectile dysfunction in subjects with suboptimal response to phosphodiesterase-5 inhibitors. J Am Coll Cardiol (2012) 2.85

Carotid artery stenting vs carotid endarterectomy: meta-analysis and diversity-adjusted trial sequential analysis of randomized trials. Arch Neurol (2010) 2.83

Factors affecting long-term survival following renal artery stenting. Catheter Cardiovasc Interv (2007) 2.83

The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol (2004) 2.78

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol (2012) 2.78

Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation (2006) 2.72

2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2011) 2.71

Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials. BMJ (2012) 2.66

Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA (2008) 2.59

Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv (2011) 2.57

A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease. J Am Coll Cardiol (2005) 2.56

Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol (2005) 2.56

Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials. J Am Coll Cardiol (2008) 2.54

Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation (2002) 2.53

Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv (2010) 2.52

Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol (2005) 2.50

Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial. Circulation (2009) 2.39

The Carotid Revascularization Endarterectomy versus Stenting Trial: credentialing of interventionalists and final results of lead-in phase. J Stroke Cerebrovasc Dis (2010) 2.35

Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation (2004) 2.35

Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial. Circulation (2004) 2.28

Clinical features and outcomes of carotid artery stenting by clinical expert consensus criteria: a report from the CARE registry. Catheter Cardiovasc Interv (2010) 2.21

The reporting of blinding in physical medicine and rehabilitation randomized controlled trials: a systematic review. J Rehabil Med (2013) 2.20

Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA (2006) 2.16

Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. JACC Cardiovasc Interv (2009) 2.12

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J (2011) 2.11

Troponin criteria for myocardial infarction after percutaneous coronary intervention. Arch Intern Med (2012) 2.09

Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial. J Am Coll Cardiol (2004) 2.05

Should patients with challenging anatomy be offered endovascular aneurysm repair? J Vasc Surg (2003) 2.04

Effect of endothelial shear stress on the progression of coronary artery disease, vascular remodeling, and in-stent restenosis in humans: in vivo 6-month follow-up study. Circulation (2003) 2.04

Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA (2006) 2.03

Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry. Circulation (2008) 2.01

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions. Am Heart J (2010) 2.00

Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation (2005) 2.00

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg (2012) 1.99

Contemporary analysis of descending thoracic and thoracoabdominal aneurysm repair: a comparison of endovascular and open techniques. Circulation (2008) 1.99

Coronary artery spatial distribution of acute myocardial infarction occlusions. Circulation (2004) 1.96

Screening for abdominal aortic aneurysm: a consensus statement. J Vasc Surg (2004) 1.96

Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther (2012) 1.95

Medical device development: from prototype to regulatory approval. Circulation (2004) 1.90

No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J (2003) 1.87

Anomalous origin of the right coronary artery from the left coronary sinus: case report and literature review. Tex Heart Inst J (2002) 1.87

Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients. J Vasc Surg (2006) 1.83

Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation (2004) 1.83

A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial. J Am Coll Cardiol (2010) 1.80

Myocardial infarction after carotid stenting and endarterectomy: results from the carotid revascularization endarterectomy versus stenting trial. Circulation (2011) 1.78

ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting). J Am Coll Cardiol (2007) 1.78

The United States preventive services task force recommendation statement on screening for peripheral arterial disease: more harm than benefit? Circulation (2006) 1.76

The Carotid Artery Revascularization and Endarterectomy (CARE) registry: objectives, design, and implications. Catheter Cardiovasc Interv (2008) 1.75

Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv (2011) 1.75

The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation (2012) 1.75

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg (2012) 1.74